Managing Hypertension and Chronic Kidney Disease

Hypertension and chronic kidney disease are closely linked conditions that frequently occur together and each makes the other harder to manage. High blood pressure damages the blood vessels within the kidneys over time, reducing their ability to filter blood effectively. When kidney function declines, the kidneys lose their capacity to regulate blood pressure normally, which causes blood pressure to rise further. This two-way relationship means that both conditions must be managed simultaneously and consistently to slow the progression of damage to both organs.

This article explains how hypertension and chronic kidney disease interact, how they are diagnosed and staged, what treatment involves, which symptoms and changes warrant urgent medical attention, and how to manage both conditions effectively over the long term.
 

When to Seek Urgent Medical Care

The following symptoms or changes require prompt medical attention and should not be managed at home or waited upon:

• Blood pressure consistently above 160/100 mmHg despite taking prescribed medications
• Sudden significant weight gain of one to two kilograms or more over a day or two, which may indicate fluid retention
• Swelling of the legs, ankles, or face that is new or worsening rapidly
• Markedly reduced urine output, or urine that appears dark, tea-coloured, or bloody
• Breathlessness at rest or when lying flat, or a persistent cough with frothy sputum, which may indicate fluid in the lungs
• Severe headache, visual disturbance, or confusion with very high blood pressure, which may indicate a hypertensive emergency
• Chest pain or palpitations
• New or worsening nausea, loss of appetite, metallic taste, or severe fatigue that interferes with daily function

If you experience severe breathlessness, chest pain, confusion, or are unable to pass urine, seek emergency care immediately rather than waiting for a routine appointment.
 

How Hypertension and Chronic Kidney Disease Are Connected

The kidneys filter blood continuously, removing waste products and excess fluid through millions of tiny filtering units called nephrons. Within each nephron is a cluster of small blood vessels called the glomerulus, which is where the actual filtration of blood occurs. These structures are sensitive to changes in blood pressure.

Sustained high blood pressure exerts mechanical stress on the walls of the glomerular blood vessels. Over time, this causes scarring of the filtration units, a process called glomerulosclerosis, which progressively reduces the kidneys' ability to filter blood efficiently.

Damaged kidneys in turn lose their ability to regulate blood pressure. Healthy kidneys produce hormones and regulate fluid and electrolyte balance in ways that keep blood pressure within a normal range. When kidney function is impaired, this regulation fails in several ways. The kidneys may overproduce renin, a hormone that triggers a cascade causing blood vessel constriction and salt and water retention, leading to further blood pressure elevation. The kidneys may also fail to excrete sufficient sodium and water, causing an increase in blood volume that raises blood pressure mechanically.

The result is a cycle in which high blood pressure damages the kidneys and damaged kidneys worsen blood pressure, each reinforcing the other. Breaking this cycle through sustained blood pressure control is the central goal of treatment.
 

Causes and Risk Factors

Hypertension and chronic kidney disease share many risk factors and are frequently caused by the same underlying conditions.

Diabetes is the leading cause of chronic kidney disease and kidney failure worldwide. High blood glucose damages the blood vessels throughout the body, including those in the kidneys. When diabetes and hypertension coexist, kidney damage progresses significantly faster than with either condition alone.

Long-standing, poorly controlled hypertension is itself a major cause of chronic kidney disease, independent of other conditions. The risk is proportional to the degree and duration of blood pressure elevation. People who have had high blood pressure for many years without adequate treatment face the highest risk.

Glomerulonephritis, which is inflammation of the kidney's filtration units, can be caused by infections, autoimmune conditions such as lupus, or IgA nephropathy, and can lead to both chronic kidney disease and hypertension.

Genetic conditions including polycystic kidney disease cause structural damage to the kidneys that leads to hypertension and progressive kidney failure.

Frequent or long-term use of non-steroidal anti-inflammatory drugs including ibuprofen, naproxen, and diclofenac reduces blood flow to the kidneys, can cause direct kidney damage, and may raise blood pressure. These drugs should be avoided or used only briefly and with medical guidance in people with kidney disease or hypertension.

Smoking damages the renal arteries and is associated with accelerated progression of both hypertension and chronic kidney disease. Stopping smoking is one of the most important modifiable risk factors.

Obesity is associated with both hypertension and chronic kidney disease through several mechanisms including increased blood volume, activation of hormonal systems that raise blood pressure, and direct metabolic effects on the kidneys.

A family history of kidney disease, hypertension, diabetes, or cardiovascular disease increases individual risk. People with a strong family history should be screened for kidney disease and blood pressure problems at a younger age.
 

How Both Conditions Are Diagnosed and Monitored

Because both hypertension and early chronic kidney disease usually cause no symptoms until they are significantly advanced, diagnosis depends almost entirely on testing. Regular monitoring is the only reliable way to detect deterioration before it becomes severe.
 

Blood Pressure Measurement

Blood pressure should be measured using a calibrated device with the person seated and rested. A single high reading does not diagnose hypertension; the diagnosis is based on consistently elevated readings on multiple occasions. Home blood pressure monitoring, using a validated device, is valuable because it captures readings outside the clinical setting and provides more data for treatment decisions. Blood pressure targets in chronic kidney disease are generally set at below 130 over 80 millimetres of mercury, though the specific target may be adjusted based on the individual's age, degree of proteinuria, and other clinical factors. This should be agreed upon with the treating doctor.
 

Kidney Function: eGFR

The estimated glomerular filtration rate, known as the eGFR, is calculated from the serum creatinine level, age, and sex. Creatinine is a waste product from muscle metabolism that is filtered solely by the kidneys. When kidney filtration declines, creatinine accumulates in the blood and the eGFR falls. The eGFR is expressed as a number representing the approximate percentage of normal kidney filtering capacity that remains.

Chronic kidney disease is classified into five stages based on the eGFR. Stage one has an eGFR of 90 or above with evidence of kidney damage such as proteinuria. Stage two has an eGFR of 60 to 89. Stage three, which is further divided into 3a and 3b, covers eGFR values between 30 and 59 and represents moderate loss of kidney function. Stage four, with an eGFR of 15 to 29, represents severely reduced kidney function. Stage five, with an eGFR below 15, represents kidney failure and is the point at which renal replacement therapy such as dialysis or transplantation is typically considered. Earlier stages focus on slowing progression and managing complications; later stages require preparation for renal replacement if decline continues.
 

Proteinuria: Urine Albumin-to-Creatinine Ratio

Under normal conditions, the kidney's filtration barrier prevents large proteins such as albumin from passing into the urine. When this barrier is damaged by hypertension or other causes, albumin leaks into the urine. The urine albumin-to-creatinine ratio, known as the UACR, quantifies this leakage and is one of the most sensitive early markers of kidney damage. It is particularly important because proteinuria is itself a driver of further kidney injury, and reducing proteinuria through blood pressure control and medication is a treatment goal in its own right. Proteinuria also significantly increases cardiovascular risk.

Other Investigations

Renal ultrasound assesses the size, structure, and appearance of the kidneys. Chronic kidney disease from long-standing hypertension is often associated with reduced kidney size. The ultrasound also excludes structural causes of kidney disease such as obstruction or cysts.

Blood tests for electrolytes, particularly potassium and bicarbonate, are routinely monitored because kidney disease impairs the regulation of these substances. Anaemia is assessed through a full blood count, as the kidneys produce erythropoietin, the hormone that stimulates red blood cell production, and declining kidney function reduces this. Calcium, phosphate, and parathyroid hormone levels are monitored in more advanced stages because the kidneys play a central role in mineral metabolism. Fasting glucose and HbA1c assess for diabetes or impaired glucose regulation. Blood cholesterol and lipid levels are measured because dyslipidaemia is common and contributes to cardiovascular risk in this population.

Symptoms

Both hypertension and early to moderate chronic kidney disease are typically silent, meaning they cause no symptoms that the person notices. This is one of the most clinically important features of both conditions. Damage accumulates silently over years, and by the time symptoms appear, significant function has often been lost.

As kidney disease progresses to more advanced stages, symptoms begin to emerge. Fluid retention causes swelling in the ankles, feet, and lower legs, and in some cases around the eyes, particularly in the morning. Weight may increase due to retained fluid. Nocturia, which is waking at night to pass urine more frequently than usual, may occur as the kidneys lose their ability to concentrate urine effectively. Frothy urine, due to protein in the urine, may be noticed.

In advanced kidney disease, the accumulation of metabolic waste products that the kidneys can no longer clear causes a constellation of symptoms including persistent nausea, loss of appetite, a metallic or unpleasant taste in the mouth, persistent fatigue and weakness, difficulty concentrating, and in some cases an itching sensation affecting the skin. Anaemia contributes to fatigue and breathlessness on exertion. Blood pressure becomes increasingly difficult to control as kidney function falls.

Very high blood pressure can occasionally cause symptoms including headache, visual disturbance, and dizziness, but most people with hypertension have no symptoms even at significantly elevated levels. Blood pressure should not be managed based on how the person feels; it requires measurement.
 

Treatment

Blood Pressure Medications

ACE inhibitors and angiotensin receptor blockers, commonly known as ARBs, are the preferred first-line blood pressure medicines in people with chronic kidney disease, particularly when proteinuria is present. These drugs reduce the pressure within the kidney's filtration units beyond their blood pressure-lowering effect, which slows the progression of kidney damage and reduces proteinuria. Examples of ACE inhibitors include ramipril and lisinopril; examples of ARBs include losartan and telmisartan. These should not be used together, as the combination increases the risk of hyperkalaemia without additional benefit over either agent alone.

A small rise in creatinine of up to twenty to thirty percent, and a modest rise in potassium, is expected and acceptable when these medicines are started or doses are increased, and does not indicate kidney damage. However, a larger or rapid rise requires medical review and possibly dose adjustment or a change in medication. Blood tests should be checked within one to two weeks of starting or significantly changing the dose.

Most people with chronic kidney disease and hypertension require more than one blood pressure medicine to reach the target. Calcium channel blockers, diuretics, and beta-blockers are commonly added depending on the individual's clinical situation. The specific combination is chosen by the doctor based on the stage of kidney disease, electrolyte levels, comorbidities, and tolerability. Patients should not adjust or stop blood pressure medications without discussing this with their doctor, as doing so can cause significant fluctuations in blood pressure and kidney function.
 

SGLT2 Inhibitors

SGLT2 inhibitors, a class of medications originally developed for type 2 diabetes, have demonstrated significant benefits in slowing the progression of chronic kidney disease in people with or without diabetes. Medicines such as dapagliflozin and empagliflozin have been shown in large clinical trials to reduce the risk of kidney failure, hospitalisation from heart failure, and cardiovascular events in people with CKD. They are now recommended in major international guidelines for people with chronic kidney disease who meet specific clinical criteria, subject to eGFR thresholds. Whether they are appropriate for an individual patient should be assessed by their nephrologist or physician.
 

Diet and Sodium Reduction

Reducing sodium intake is one of the most important and effective dietary changes for managing blood pressure in people with kidney disease. The kidneys are central to sodium excretion, and impaired kidneys retain sodium more readily, contributing to fluid overload and elevated blood pressure. A sodium intake of less than two grams per day, equivalent to approximately five grams of table salt, is generally recommended for people with chronic kidney disease and hypertension.

In practice, most sodium in the Indian diet comes from processed foods, pickles, papads, salted snacks, restaurant meals, and cooking salt added during preparation. Reading food labels, reducing consumption of high-sodium packaged foods, and flavouring food with herbs, lemon, and spices rather than salt are practical approaches. Potassium-based salt substitutes should not be used by people with chronic kidney disease without explicit medical approval, as the kidneys may be unable to excrete the extra potassium, creating a risk of hyperkalaemia, which can affect heart rhythm.

Potassium restriction may be necessary in later stages of chronic kidney disease when the kidneys can no longer excrete potassium normally. Foods high in potassium include bananas, oranges, tomatoes, potatoes, nuts, and dairy products. Whether restriction is needed and to what degree depends on the individual's blood potassium level and should be guided by a doctor or renal dietitian. Not all people with CKD need to restrict potassium, and unnecessary restriction can reduce the nutritional quality of the diet.

Protein intake may need to be moderated in advanced chronic kidney disease to reduce the nitrogenous waste load on the kidneys. This recommendation is stage-dependent and should be individualised. Protein restriction should not be undertaken without the guidance of a renal dietitian, as inadequate protein in a person with chronic illness can lead to malnutrition and muscle loss, both of which worsen outcomes. In people with diabetes and CKD, glycaemic control is integral to the management plan and affects both kidney progression and cardiovascular risk.
 

Fluid Management

In early and moderate chronic kidney disease, fluid intake usually does not need to be formally restricted. As kidney disease advances and fluid retention becomes a problem, a doctor may advise a specific daily fluid limit. Any fluid limit given by a doctor should be followed carefully. Sudden significant weight gain over a day or two is a reliable indicator of fluid retention and should prompt contact with the medical team.
 

Lifestyle Modifications

Stopping smoking significantly reduces the rate of kidney function decline and lowers cardiovascular risk. It is one of the most impactful changes a person with hypertension and kidney disease can make.

Regular physical activity of moderate intensity, such as brisk walking, supports blood pressure control, weight management, cardiovascular health, and overall wellbeing. The appropriate type and level of activity should be discussed with the doctor, particularly in advanced disease or when cardiovascular symptoms are present.

Weight management reduces the metabolic and mechanical burden on the kidneys and supports blood pressure control. Even modest weight reduction in overweight individuals can reduce blood pressure meaningfully.

Alcohol should be consumed within recommended limits or avoided, as it raises blood pressure and can interact with medications.

NSAIDs including ibuprofen, diclofenac, and naproxen should be avoided by people with kidney disease. They reduce blood flow to the kidneys, can cause acute kidney injury, worsen fluid retention, and raise blood pressure. Paracetamol within the recommended dose is generally a safer analgesic option for most people with CKD, though any pain medicine should be discussed with the doctor.

Herbal and traditional remedies, high-dose supplements, and over-the-counter products should not be taken without discussing them with the treating doctor. Many herbal preparations contain substances that are directly toxic to the kidneys or that interact with blood pressure medicines. This is particularly relevant for ayurvedic and traditional preparations, some of which contain heavy metals or compounds that are harmful to compromised kidneys.
 

Complications of Uncontrolled Hypertension and Chronic Kidney Disease

When either condition is inadequately controlled, the risk of serious complications increases substantially.

Cardiovascular disease is the leading cause of death in people with chronic kidney disease. Hypertension, proteinuria, anaemia, dyslipidaemia, and mineral metabolism disturbances all contribute to accelerated cardiovascular risk. Heart attack, stroke, heart failure, and sudden cardiac death are all significantly more common in people with CKD than in the general population. Blood pressure control, lipid management, and smoking cessation are integral to reducing this risk.

Hyperkalaemia, which is a high blood potassium level, occurs when the kidneys can no longer excrete potassium effectively. It can cause dangerous cardiac arrhythmias and is life-threatening at very high levels. It is one of the reasons that monitoring electrolytes regularly is essential in this population, and why potassium-containing salt substitutes and high-potassium diets require careful consideration.

Renal anaemia results from reduced erythropoietin production by the damaged kidneys and contributes to fatigue, reduced exercise tolerance, and cardiovascular strain. It is treated with erythropoiesis-stimulating agents and sometimes intravenous iron, as directed by the nephrologist.

Metabolic acidosis, hyperphosphataemia, and secondary hyperparathyroidism are metabolic complications of advanced chronic kidney disease that affect bone health, cardiovascular risk, and overall wellbeing and require specific management.

Progression to kidney failure requiring dialysis or transplantation is the ultimate consequence of uncontrolled or rapidly progressing disease. Slowing this progression through blood pressure control, renoprotective medications, and lifestyle management is the central aim of treatment.
 

Monitoring and Follow-Up

Regular monitoring is not optional in the management of hypertension and chronic kidney disease. It is essential. The frequency of monitoring depends on the stage of disease and the stability of the clinical situation, and should be guided by the treating nephrologist or physician.

As a general guide, blood pressure should be checked at every clinical visit and twice daily at home where possible. Blood tests including creatinine, eGFR, electrolytes, and haemoglobin are typically checked every three to six months in stable earlier-stage disease and more frequently in later stages or when medication changes have been made. The urine albumin-to-creatinine ratio is typically measured annually or more frequently in high-risk patients. Blood glucose and HbA1c are checked regularly in people with diabetes.

When ACE inhibitors, ARBs, or SGLT2 inhibitors are started or doses changed, blood tests should be checked within one to two weeks to assess the effect on creatinine and potassium. Any test result or symptom that causes concern should prompt contact with the medical team between scheduled appointments.

People with advanced chronic kidney disease should be under the care of a nephrologist and should have discussions about renal replacement therapy options, including different forms of dialysis and kidney transplantation, well in advance of kidney failure, so that preparation can be made in a planned and timely way.

Frequently Asked Questions

1. Why did my creatinine level rise when I started my blood pressure medicine?

ACE inhibitors and ARBs cause a modest and expected rise in creatinine when first started. This is a normal response that reflects the medicines working to reduce pressure within the kidney's filtration units. A rise of up to twenty to thirty percent that stabilises is generally acceptable and does not mean the medicine is harming the kidneys. Your doctor will check a blood test within one to two weeks of starting or changing the dose to confirm the rise is within an acceptable range.
 

2. Can I use potassium-based salt substitutes?

Not without asking your doctor first. Most salt substitutes replace sodium with potassium chloride. In people with chronic kidney disease, the kidneys may not be able to excrete the extra potassium, which can raise blood potassium to dangerous levels and affect heart rhythm. Whether a potassium-containing substitute is safe for you depends on your current kidney function and potassium level, and should be assessed individually.
 

3. Is exercise safe with kidney disease and high blood pressure?

Regular moderate exercise is generally beneficial and recommended for people with hypertension and chronic kidney disease. It helps lower blood pressure, improve cardiovascular fitness, support weight management, and maintain muscle mass. Brisk walking is an accessible and effective option for most people. The appropriate type and intensity of exercise should be discussed with your doctor, particularly if you have advanced kidney disease, cardiovascular symptoms, or have been relatively inactive.
 

4. Why is my blood pressure so hard to control now that my kidney function has declined?

As kidney function falls, blood pressure becomes progressively harder to control because the kidneys lose their ability to regulate sodium excretion, fluid balance, and hormone systems that affect blood vessel tone. This often means that more medicines are needed as kidney disease advances. Strict adherence to medications, sodium restriction, and fluid management become increasingly important as the disease progresses.
 

5. Can I take ibuprofen or other pain medicines?

Non-steroidal anti-inflammatory drugs including ibuprofen, naproxen, and diclofenac should generally be avoided in people with chronic kidney disease. They reduce blood flow to the kidneys, can trigger or worsen acute kidney injury, cause fluid retention, and raise blood pressure. Paracetamol within the recommended dose is generally safer for most people with CKD. Any regular pain medicine should be discussed with your treating doctor.
 

6. Why am I anaemic?

The kidneys produce erythropoietin, the hormone that signals the bone marrow to produce red blood cells. As kidney function declines, erythropoietin production falls, leading to anaemia. This is treated with erythropoiesis-stimulating agents given by injection, alongside iron supplementation when iron levels are low, under the direction of a nephrologist.
 

7. Is it safe to take herbal or traditional medicines?

Not without discussing them with your doctor. Several herbal and traditional preparations, including some ayurvedic formulations, contain substances that are directly toxic to the kidneys or that interact with blood pressure medications. The kidneys' reduced ability to excrete certain compounds also means that substances safe in healthy individuals can accumulate to harmful levels in people with CKD. Always inform your treating doctor about everything you take, including herbal, traditional, and over-the-counter preparations.
 

8. Will I definitely need dialysis?

Not necessarily. The rate at which kidney disease progresses varies considerably between individuals and depends heavily on how well blood pressure, blood glucose, proteinuria, and other modifiable factors are managed. Many people with chronic kidney disease live for decades without reaching kidney failure, particularly when the condition is identified and treated early. However, in some cases, particularly when kidney disease is advanced at diagnosis or when progression is rapid, dialysis or transplantation may eventually become necessary. This is why ongoing monitoring and consistent management are important.
 

9. How much fluid should I drink each day?

In early and moderate chronic kidney disease, there is usually no need to restrict fluid intake. If your doctor has given you a specific fluid limit, this should be followed carefully. For most people without a specific restriction, drinking when thirsty and monitoring body weight for sudden increases, which suggest fluid retention, are practical guides. Do not significantly increase fluid intake without discussing this with your doctor, particularly in later stages of kidney disease.
 

10. Can a low-sodium diet really make a difference to my blood pressure?

Yes, meaningfully so. Sodium reduction is one of the most effective non-medication interventions for blood pressure in people with kidney disease. The kidneys in CKD retain sodium more readily than healthy kidneys, making this population particularly sensitive to sodium intake. Consistently reducing sodium intake to less than two grams per day is associated with a meaningful reduction in blood pressure and often reduces the number or dose of medicines needed. The effect becomes apparent within two to four weeks of sustained reduction
 

Key Takeaways

• Hypertension and chronic kidney disease form a cycle in which each condition worsens the other. Managing both simultaneously is essential.
• Both conditions are usually silent until advanced. Regular blood tests and blood pressure monitoring are the only way to detect deterioration early.
• The eGFR and the urine albumin-to-creatinine ratio are the key tests for monitoring kidney function and kidney damage. Both should be checked regularly as advised by the treating doctor.
• ACE inhibitors and ARBs are the preferred blood pressure medicines in chronic kidney disease, particularly when proteinuria is present. They slow progression beyond their blood pressure-lowering effect. SGLT2 inhibitors are now also recommended in appropriate patients.
• Sodium restriction to less than two grams per day is one of the most effective non-medication treatments and makes blood pressure medications work more effectively.
• NSAIDs including ibuprofen, naproxen, and diclofenac should be avoided in kidney disease. Potassium-containing salt substitutes require medical approval before use.
• Stopping smoking, maintaining a healthy weight, and regular moderate exercise are important lifestyle measures that slow disease progression.
• Any herbal, traditional, or over-the-counter products should be discussed with the treating doctor before use, as many are harmful to damaged kidneys.
• Seek urgent medical attention for sudden weight gain, significantly reduced urine output, new or worsening breathlessness, chest pain, severe headache with very high blood pressure, or blood in the urine.